There's a raging debate around climate change and intellectual property, and the planet's fate may be linked to the way we think about patent protectionism.
G77 countries at the Bonn climate conference were been demanding access to green technology intellectual property, as a requirement for moving ahead. Industrialized countries have been stonewalling, arguing that greentech IP is private, and can't be shared. G77 countries have come back with a proposal where developed nations would pay into a pool that would buy access to greentech IP, to be shared with developing nations, which has been worrying US politicians advocating for stronger IP rights. This is one of several important threads involved in international climate negotiations, but has been substantially underreported on in the American IP reform community.
I'm particularly interested by India's comparison of greentech IP to essential HIV/AIDS drugs, framing their current demands in light of a widely understood battle over patent protection vs. humanitarian access. I'm hoping to see more folks pick up on this angle, and see where the comparison works, and where it doesn't.